We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
NF-κB inhibition delays DNA damage-induced senescence and aging in mice.
- Authors
Tilstra, Jeremy S; Robinson, Andria R; Wang, Jin; Gregg, Siobhán Q; Clauson, Cheryl L; Reay, Daniel P; Nasto, Luigi A; St Croix, Claudette M; Usas, Arvydas; Vo, Nam; Huard, Johnny; Clemens, Paula R; Stolz, Donna B; Guttridge, Denis C; Watkins, Simon C; Garinis, George A; Wang, Yinsheng; Niedernhofer, Laura J; Robbins, Paul D
- Abstract
The accumulation of cellular damage, including DNA damage, is thought to contribute to aging-related degenerative changes, but how damage drives aging is unknown. XFE progeroid syndrome is a disease of accelerated aging caused by a defect in DNA repair. NF-κB, a transcription factor activated by cellular damage and stress, has increased activity with aging and aging-related chronic diseases. To determine whether NF-κB drives aging in response to the accumulation of spontaneous, endogenous DNA damage, we measured the activation of NF-κB in WT and progeroid model mice. As both WT and progeroid mice aged, NF-κB was activated stochastically in a variety of cell types. Genetic depletion of one allele of the p65 subunit of NF-κB or treatment with a pharmacological inhibitor of the NF-κB-activating kinase, IKK, delayed the age-related symptoms and pathologies of progeroid mice. Additionally, inhibition of NF-κB reduced oxidative DNA damage and stress and delayed cellular senescence. These results indicate that the mechanism by which DNA damage drives aging is due in part to NF-κB activation. IKK/NF-κB inhibitors are sufficient to attenuate this damage and could provide clinical benefit for degenerative changes associated with accelerated aging disorders and normal aging.
- Publication
The Journal of clinical investigation, 2012, Vol 122, Issue 7, p2601
- ISSN
1558-8238
- Publication type
Journal Article
- DOI
10.1172/JCI45785